graphical illustration statistical analysis perform use graphpad prism03 version 9.3.1. graphpad software inc. san diego ca usa data also analyse spss statistic version 23 ibm co. armonk ny usa statistical significance set p ≤ 0.05 p ≤ 0.01 p ≤ 0.001 p ≤ 0.0001. kruskalwallis test follow dunn 's multiple comparison post hoc test use compare mean dnam perform among four subject group multivariate linear regression model employ examine association dnam vs. pan dnam vs. duration antipsychotic treatment dot table 1 show demographic 4 subgroup medication give pan score cohort 4 subgroup healthy control hc ultrahigh risk uhr firstepisode fe chronic schizophrenia c total 199 participant 93 males,106 female consist 4 subgroup hc 56 uhr 87 fe 26 c 30 recruit study participant almost equal number male female except uhr comprise higher number female subject make 84.1 chinese accurately reflect ethnic makeup singapore 's population 4 group compare crosssectionally symptom severity uhr observe highest pan score compare fe c uhr severe symptom c statistically significant higher positive 10.92 ± 0.29 vs. 9.93 ± 0.74 p 0.0453 negative 12.2 ± 0.42 vs. 8.9 ± 0.52 p 0.0001 general 25.94 ± 0.76 vs. 18.8 ± 0.53 p 0.0234 total pan score c 49.06 ± 1.21 vs. 37.63 ± 1.41 p 0.0001. one aim compare dnam crosssectionally across 4 group examine first whether bmi gender age affect dnam four group subject average bmi 4 group hc 23.06 ± 0.54 uhr 22.57 ± 0.56 fe 22.63 ± 0.78 c 25.52 ± 1.28. check association bmi dnam linear regression find bmi association dnam result show gender equal number male female cohort except uhr female see table 1. anova test note significant difference cpg4 correct result accordingly data show study effect smoke data incomplete regard age result see table 5 fig 1. separate age subject hc le 30 group 31 40 group 41 50 group 51 60 group 61 72 group compare dnam group generally dnam decrease become hypomethylated increase age however amount hypomethylation significant hc albeit wide range age study separate patient 3 group accord different stage schizophrenia e.g uhr younger c stratify age thus make adjustment age compare crosssectionally 3 group schematic diagram fig 1a show five cpg site study site transcription start site tss enhancer region region vital bind factor facilitate interaction longrange transcription factor enhancer polymerase transcription machinery near tss look dnam among 4 group uhr observe lowest dnam across study cpg site fig 1b c table 2. notable find across group comparison uhr note hypomethylated study cpg site compare hc difference significant site cpg 3 8.99 ± 0.38 vs. 7.79 ± 0.21 p 0.0075 cpg5 9.34 ± 0.36 vs. 8.01 ± 0.20 p 0.0058 average mean dnam site 8.78 ± 0.35 vs. 7.72 ± 0.19 p 0.0214 fig 1b c table 2. fe observe consistently hypomethylated study cpg site compare hc difference statistically significant observe c dnam level le hypomethylated almost level hc uhr lowest dnam level site statistically significant lower level c cpg3 7.79 ± 0.21 vs. 9.08 ± 0.53 p 0.0286 cpg5 8.01 ± 0.20 vs. 9.33 ± 0.46 p 0.0266 see fig 1c table 2. trend observe interest consider result pan score table 1. pan score uhr highest severe among fe c however uhr dnam lowest three compare hc c score lowest le severe pan score dnam highest level hc trend may indicate dnam pan score inverse correlation observe significant difference dnam level uhr c thus attempt investigate antipsychotic intake drive force behind difference filter group accord medication regime 1 select uhr psychotrophics uhr 2 select fe antipsychotic fe ap 3 select c antipsychotic c ap observe uhr lowest dnam cpg site among subgroup notable difference among subgroup difference dnam level may due treatment antipsychotic ap find whether treatment effect ap affect mean dnam level cpg site correlate duration antipsychotic treatment dot mean dnam much significance find cohort fe ap c ap table 6a b respectively however interest trend fe ap subject early stage treatment le 4 week aps treatment much correlation dnam find table 6a c ap dot seem stronger correlation dnam see cpg5 spearman 's rank r 0.357 p 0.103 table 6b c ap slightly stronger correlation dnam could c ap cohort take ap much longer period fe ap recall dnam uhr fe c seem inverse relationship pan score next check pan score three group aps want know pan score cohort show inverse trend dnam fig 3 observe uhr highest pan score total general positive negative c ap lowest pan score uhr c ap significantly different total 44.76 ± 1.49 vs. 36.04 ± 1.55 p 0.0002 general 23.63 ± 0.88 vs. 18.30 ± 0.58 p 0.0001 negative pan score 10.95 ± 0.65 vs. 8.39 ± 0.47 p 0.0040 see table 4. fe ap score second highest 4 category trend inversely relate dnam profile uhr fe ap c ap fig 2. seem antipsychotic treatment might lower score two symptom schizophrenia negative general symptom however patient also receive nonmedication therapy like counsel etc. pan score total effort treatment dna methylations affect medication environmental factor know well dnam associate pan score correlation dnam pan score linear regression explore association reln dnam pan employ multivariate linear regression control age gender dnam level pan respective group association strong association indicate dnam could associate higher biological function like behaviour observe significant association reln dnam cpg2 r 0.227 08 0.388 p 0.039 cpg3 r 0.233 08 0.398 p 0.034 cpg5 r 0.306 08 0.408 p 0.024 average mean dnam site r 0.237 08 0.401 p 0.033 pan negative score table 2. r suggest around 30.6 population fe dnam cpg5 could explain predict negative pan score beta value describe prediction 's strength direction higher value reflect stronger prediction negative beta value 0.408 mean inverse relation mean methylation increase 1 unit negative pan score decrease 0.408 unit similar deduction could draw association cpg2 cpg3 average five site show fig 1 mean dnam value increase uhr fe negative pan score table 1 decrease uhr fe show inverse relationship result association see table 2 indicate fe dnam could predict negative behaviour pan score dnam pan score cohort take ap associate fe ap pan score adjust age gender fe ap cpg5 close significant association negative pan score see table 2 adjust r 0.23 beta 0.468 p 0.057. summary data set fe dnam data associate well negative behaviour fe patient likewise fe ap dnam also show association fe ap negative pan score result close